
STARStrides Pharma Science Ltd.
Strides Pharma Science Q2 FY27 Results: Consolidated Net Profit ₹134 Crore on Total Income of ₹1,434 Crore
Strides Pharma Science (NSE: STAR) reported consolidated total income of ₹1,433.82 crore and net profit of ₹134.12 crore for the quarter ended 30 Sep 2026, it said in a filing on 29 Oct 2026. Standalone total income was ₹661.29 crore and standalone net profit ₹9.26 crore for the same quarter.
- Earnings
- Pharmaceuticals